19-14587676-C-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001204118.2(CLEC17A):​c.184C>A​(p.Leu62Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 152,088 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000055 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CLEC17A
NM_001204118.2 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.29
Variant links:
Genes affected
CLEC17A (HGNC:34520): (C-type lectin domain containing 17A) Enables fucose binding activity; identical protein binding activity; and mannose binding activity. Located in cell surface. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22844273).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CLEC17ANM_001204118.2 linkuse as main transcriptc.184C>A p.Leu62Ile missense_variant 3/14 ENST00000417570.6 NP_001191047.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CLEC17AENST00000417570.6 linkuse as main transcriptc.184C>A p.Leu62Ile missense_variant 3/141 NM_001204118.2 ENSP00000393719 P1Q6ZS10-1
CLEC17AENST00000339847.9 linkuse as main transcriptc.184C>A p.Leu62Ile missense_variant, NMD_transcript_variant 3/131 ENSP00000341620 Q6ZS10-2
CLEC17AENST00000551730.1 linkuse as main transcriptc.184C>A p.Leu62Ile missense_variant, NMD_transcript_variant 3/141 ENSP00000447424
CLEC17AENST00000547437.5 linkuse as main transcriptc.184C>A p.Leu62Ile missense_variant 3/132 ENSP00000450065 Q6ZS10-3

Frequencies

GnomAD3 genomes
AF:
0.0000132
AC:
2
AN:
152088
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000129
AC:
3
AN:
232924
Hom.:
0
AF XY:
0.0000159
AC XY:
2
AN XY:
126064
show subpopulations
Gnomad AFR exome
AF:
0.0000702
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000348
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000550
AC:
8
AN:
1453996
Hom.:
0
Cov.:
32
AF XY:
0.00000415
AC XY:
3
AN XY:
722576
show subpopulations
Gnomad4 AFR exome
AF:
0.0000300
Gnomad4 AMR exome
AF:
0.0000231
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000271
Gnomad4 OTH exome
AF:
0.0000499
GnomAD4 genome
AF:
0.0000132
AC:
2
AN:
152088
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000113
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 27, 2024The c.184C>A (p.L62I) alteration is located in exon 3 (coding exon 3) of the CLEC17A gene. This alteration results from a C to A substitution at nucleotide position 184, causing the leucine (L) at amino acid position 62 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.37
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Benign
0.018
.;T
Eigen
Uncertain
0.26
Eigen_PC
Benign
0.16
FATHMM_MKL
Benign
0.65
D
LIST_S2
Benign
0.48
T;T
M_CAP
Benign
0.0084
T
MetaRNN
Benign
0.23
T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
1.7
L;L
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.35
N;N
REVEL
Benign
0.057
Sift
Pathogenic
0.0
D;D
Sift4G
Benign
0.14
T;T
Polyphen
1.0
D;D
Vest4
0.31
MutPred
0.26
Loss of catalytic residue at L62 (P = 0.0137);Loss of catalytic residue at L62 (P = 0.0137);
MVP
0.70
MPC
3.0
ClinPred
0.51
D
GERP RS
2.3
Varity_R
0.14
gMVP
0.013

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs371803480; hg19: chr19-14698488; API